a b s t r a c t 30 Didox (3,4-dihydroxy-benzohydroxamic acid), is a synthetic ribonucleotide reductase (RR) inhibitor 31 derived from polyhydroxy-substituted benzohydroxamic acid, and originally developed as an anti-cancer 32 agent. Some studies indicate that didox may have anti-oxidative stress-like properties, while other stud- 33 ies hint that didox may have anti-inflammatory properties. Using nitric oxide production in response to 34 LPS treatment as a sensitive screening assay for anti-inflammatory compounds, we show that didox is 35 very potent at levels as low as 6.25 lM, with maximal inhibition at 100 lM. A qRT-PCR array was then 36 employed to screen didox for other potential anti-inflammatory and anti-oxidative stress-related 37 properties. Didox was very potent in suppressing the expression of these arrayed mRNA in response to 38 LPS, and in some cases didox alone suppressed expression. Using qRT-PCR as a follow up to the array, 39 we demonstrated that didox suppresses LPS-induced mRNA levels of iNOS, IL-6, IL-1, TNF-a, NF-jb 40 (p65), and p38-a, after 24 h of treatment. Treatment with didox also suppresses the secretion of nitric 41 oxide, IL-6, and IL-10. Furthermore, oxidative stress, as quantified by intracellular ROS levels in response 42 to macrophage activators LPS and phorbol ester (PMA), and the glutathione depleting agent BSO, is 43 reduced by treatment with didox. Moreover, we demonstrate that nuclear translocation of NF-jb (p65) 44 in response to LPS is inhibited by didox. These findings were supported by qRT-PCR for oxidative stress 45 genes SOD1 and catalase. Overall, this study supports the conclusion that didox may have a future role in 46 managing acute and chronic inflammatory diseases and oxidative stress due to high production of ROS. 
Introduction

52
Inflammation is often considered to be a localized physiological 53 response to tissue damage, pathogen entry into extravascular 54 spaces, and release of cellular debris from disrupted tissue integ- 55 rity and necrosis [1, 2] . From a classical perspective, such responses, 56 including recruitment of granulocytes from microvasculature, exu-57 date accumulation, and increased local blood supply, are normal 58 aspects of wound healing that ultimately lead to wound resolution 59 and restoration to healthy tissues. Chronic inflammation, on the 60 other hand, may lead to tissue destruction and loss of normal func-61 tion associated with inflamed tissues, as can be seen in rheumatoid 62 arthritis for example. More subtle forms of chronic inflammation 63 are now ascribed to broadly defined disease states such as obesity 64 [3,4], atherosclerosis [5] , type II diabetes [3] , and some forms of 65 cancer [6, 7] . 66 Because of their wide tissue distribution, macrophages are stra-67 tegically located to provide an immediate defense against not only 68 pathogens, but damaged tissues as well, which can lead to inflam-69 matory responses to endogenous danger signals [2, 8, 9] . 70 Macrophages, therefore, are a logical target for therapeutic 71 approaches to treating chronic inflammation and oxidative stress 72 associated with inflammation [10] , and especially if macrophages 73 can be polarized at will using non-toxic pharmacological interven-74 tions. With regard to anti-inflammatory agents, glucocorticoids 75 and non-steroidal anti-inflammatory drugs (NSAID) are the most 76 widely prescribed, yet both have negative long-terms side effects. 77 For example, many glucocorticoids inhibit pro-inflammatory 78 transcription factors, like NF-jb, AP-1, and SMAD3, but also may 79 disrupt the hypothalamic-pituitary-adrenal axis [11] . NSAIDs, 80 such as aspirin and selective COX-2 inhibitors (e.g., Celecoxib) 37°C to detect total superoxide as previously described [44, 45] .
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The slides were washed twice with PBS, fixed with chilled absolute 307 methanol for 1 min and mounted using glycerol:PBS (9:1) solution.
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The cover slip was placed over the mounting medium and the 309 slides were sealed using nail polish. TGT GAT GGG TGT GAA CCA CGA GAA  57  115  R: ACC CTG TTG CTG TAG CCG TAT TCA  IL-6  NC_000071.5  F: TTG TAC AGT CCC AGT CAG GCA ACA  58  80  R: TCA AGC TAC TGC AGG CCA GTT inducer for expression of IL-6, iNOS, TNF-a, and COX-2 (Fig. 2) .
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Didox inhibited LPS-induced IL-6, COX-2, and iNOS expression, with 410 the most impact on iNOS and TNF-a. Expression of both p65 and 411 p38 were enhanced by LPS treatment, and reduced by treatment 412 with didox (Fig. 3) . Expression of p65 mRNA was nearly 10-fold 413 higher than p38 in LPS-treated cells (see Fig. 4 ). The effects of didox a potent stimulator for production of NO by iNOS ( Fig. 5A and B) . (Fig. 7) . The highest level of ROS pro-452 duction was in cells treated simultaneously with PMA and BSO. 
Discussion
473
In this study we examined the effects of didox on pro- 
